"Where the company failed was that this should have been relayed to the market when this became apparent or at least when they announced the beginning of the trial as most where under the impression that we were entering a phase 3 trial, the completion of which would allow us to go for licenses and get on with the job - the reason for not disclosing this is unknown but it did have the effect of delaying things and sending the share price down"
ah clyde i enjoy reading your posts. that is it in a nutshell. This should have been apparent prior to or at the time of announcing the trials. With an explanation like that the market would have been happy with the natural progression from 2a up to 3 and i believe the price would have slowly appreciated to a much more positive postion than 6c. The company has a lot to answer for for that decision. I realise it was a busy time for management and they were dealing with real problems concerning sims and HCBerlin at the time but still inexcusable!
EMS Price at posting:
6.5¢ Sentiment: LT Buy Disclosure: Held
